MFSD12
Major facilitator superfamily domain-containing protein 12
Also known as: C19orf28, MFS12_HUMAN, MGC20700, PP3501
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6NUT3
- Gene
- MFSD12
- Ensembl
- ENSG00000161091
- Chromosome
- 19
- Canonical length
- 480 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Enables cysteine transmembrane transporter activity. Involved in cysteine transmembrane transport; pigment metabolic process involved in pigmentation; and regulation of melanin biosynthetic process. Located in lysosome and melanosome. Part of late endosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
480 residues, UniProt reviewed canonical sequence.
>Q6NUT3|MFSD12
1 MGPGPPAAGA APSPRPLSLV ARLSYAVGHF LNDLCASMWF TYLLLYLHSV RAYSSRGAGL
61 LLLLGQVADG LCTPLVGYEA DRAASCCARY GPRKAWHLVG TVCVLLSFPF IFSPCLGCGA
121 ATPEWAALLY YGPFIVIFQF GWASTQISHL SLIPELVTND HEKVELTALR YAFTVVANIT
181 VYGAAWLLLH LQGSSRVEPT QDISISDQLG GQDVPVFRNL SLLVVGVGAV FSLLFHLGTR
241 ERRRPHAEEP GEHTPLLAPA TAQPLLLWKH WLREPAFYQV GILYMTTRLI VNLSQTYMAM
301 YLTYSLHLPK KFIATIPLVM YLSGFLSSFL MKPINKCIGR NMTYFSGLLV ILAFAAWVAL
361 AEGLGVAVYA AAVLLGAGCA TILVTSLAMT ADLIGPHTNS GAFVYGSMSF LDKVANGLAV
421 MAIQSLHPCP SELCCRACVS FYHWAMVAVT GGVGVAAALC LCSLLLWPTR LRRWDRDARPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MFSD12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 11
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- kidney: 49 nTPM
- skin: 41 nTPM
- hippocampal formation: 40 nTPM
- pancreas: 34 nTPM
- spinal cord: 34 nTPM
- spleen: 32 nTPM
Single-cell type
- melanocytes: 314 nCPM
- extravillous trophoblasts: 215 nCPM
- syncytiotrophoblasts: 154 nCPM
- early spermatids: 147 nCPM
- pdcs: 116 nCPM
- migrating cytotrophoblasts: 71 nCPM
Immune cell
- plasmacytoid DC: 12 nTPM
- intermediate monocyte: 7.7 nTPM
- non-classical monocyte: 7.6 nTPM
- classical monocyte: 3.6 nTPM
- memory CD4 T-cell: 2.8 nTPM
- myeloid DC: 2.7 nTPM
Brain region
- white matter: 138 nTPM
- hippocampal formation: 113 nTPM
- thalamus: 90 nTPM
- medulla oblongata: 89 nTPM
- cerebral cortex: 89 nTPM
- pons: 87 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.42
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.74
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate transport
- melanin biosynthetic process
- negative regulation of melanin biosynthetic process
- pigment metabolic process involved in pigmentation
- regulation of melanin biosynthetic process
- cysteine transmembrane transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MFSD12 as an antibody target. Whether an autoantibody or antibody against MFSD12 could matter depends on whether native MFSD12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MFSD12 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MFSD12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...